169 related articles for article (PubMed ID: 37818558)
1. Nanotechnology-based Nose-to-brain Delivery in Epilepsy: A Novel Approach to Diagnosis and Treatment.
Khan J; Yadav S
Pharm Nanotechnol; 2023 Oct; ():. PubMed ID: 37818558
[TBL] [Abstract][Full Text] [Related]
2. Management of epileptic disorders using nanotechnology-based strategies for nose-to-brain drug delivery.
Shringarpure M; Gharat S; Momin M; Omri A
Expert Opin Drug Deliv; 2021 Feb; 18(2):169-185. PubMed ID: 32921169
[TBL] [Abstract][Full Text] [Related]
3. Epilepsy Disease and Nose-to-Brain Delivery of Polymeric Nanoparticles: An Overview.
Musumeci T; Bonaccorso A; Puglisi G
Pharmaceutics; 2019 Mar; 11(3):. PubMed ID: 30871237
[TBL] [Abstract][Full Text] [Related]
4. Convolutions in the rendition of nose to brain therapeutics from bench to bedside: Feats & fallacies.
Goel H; Kalra V; Verma SK; Dubey SK; Tiwary AK
J Control Release; 2022 Jan; 341():782-811. PubMed ID: 34906605
[TBL] [Abstract][Full Text] [Related]
5. Recent Advancement in Inhaled Nano-drug Delivery for Pulmonary, Nasal, and Nose-to-brain Diseases.
Fu Q; Liu Y; Peng C; Muluh TA; Anayyat U; Liang L
Curr Drug Deliv; 2024 Jan; ():. PubMed ID: 38275044
[TBL] [Abstract][Full Text] [Related]
6. Nanotechnology for enhanced nose-to-brain drug delivery in treating neurological diseases.
Huang Q; Chen Y; Zhang W; Xia X; Li H; Qin M; Gao H
J Control Release; 2024 Feb; 366():519-534. PubMed ID: 38182059
[TBL] [Abstract][Full Text] [Related]
7. Intranasal Delivery of Nanoformulations: A Potential Way of Treatment for Neurological Disorders.
Islam SU; Shehzad A; Ahmed MB; Lee YS
Molecules; 2020 Apr; 25(8):. PubMed ID: 32326318
[TBL] [Abstract][Full Text] [Related]
8. Nanotechnology-mediated nose to brain drug delivery for Parkinson's disease: a mini review.
Kulkarni AD; Vanjari YH; Sancheti KH; Belgamwar VS; Surana SJ; Pardeshi CV
J Drug Target; 2015; 23(9):775-88. PubMed ID: 25758751
[TBL] [Abstract][Full Text] [Related]
9. A Patent Review on Nanotechnology-Based Nose-to-Brain Drug Delivery.
Singh R; Brumlik C; Vaidya M; Choudhury A
Recent Pat Nanotechnol; 2020; 14(3):174-192. PubMed ID: 32384043
[TBL] [Abstract][Full Text] [Related]
10. Nasal-nanotechnology: revolution for efficient therapeutics delivery.
Kumar A; Pandey AN; Jain SK
Drug Deliv; 2016; 23(3):681-93. PubMed ID: 24901207
[TBL] [Abstract][Full Text] [Related]
11. Formulation and characterization of lamotrigine nasal insert targeted brain for enhanced epilepsy treatment.
Abdelmonem R; El-Enin HAA; Abdelkader G; Abdel-Hakeem M
Drug Deliv; 2023 Dec; 30(1):2163321. PubMed ID: 36579655
[TBL] [Abstract][Full Text] [Related]
12. Intranasal delivery of mucoadhesive nanocarriers: a viable option for Parkinson's disease treatment?
Rehman S; Nabi B; Zafar A; Baboota S; Ali J
Expert Opin Drug Deliv; 2019 Dec; 16(12):1355-1366. PubMed ID: 31663382
[No Abstract] [Full Text] [Related]
13. Nanotechnology: an evidence-based analysis.
Medical Advisory Secretariat
Ont Health Technol Assess Ser; 2006; 6(19):1-43. PubMed ID: 23074489
[TBL] [Abstract][Full Text] [Related]
14. Alzheimer's Disease and its Related Dementia Types: A Review on Their Management
Siafaka PI; Mutlu G; Okur NÜ
Curr Alzheimer Res; 2020; 17(14):1239-1261. PubMed ID: 33602090
[TBL] [Abstract][Full Text] [Related]
15. A review of intranasal formulations for the treatment of seizure emergencies.
Kapoor M; Cloyd JC; Siegel RA
J Control Release; 2016 Sep; 237():147-59. PubMed ID: 27397490
[TBL] [Abstract][Full Text] [Related]
16. Nose-to-brain drug delivery: An update on clinical challenges and progress towards approval of anti-Alzheimer drugs.
Agrawal M; Saraf S; Saraf S; Antimisiaris SG; Chougule MB; Shoyele SA; Alexander A
J Control Release; 2018 Jul; 281():139-177. PubMed ID: 29772289
[TBL] [Abstract][Full Text] [Related]
17. Translational Considerations in the Development of Intranasal Treatments for Epilepsy.
Prentice RN; Rizwan SB
Pharmaceutics; 2023 Jan; 15(1):. PubMed ID: 36678862
[TBL] [Abstract][Full Text] [Related]
18. Unravelling Micro and Nano vesicular System in Intranasal Drug Delivery for Epilepsy.
Salave S; Rana D; Pardhe R; Bule P; Benival D
Pharm Nanotechnol; 2022 Apr; ():. PubMed ID: 35473543
[TBL] [Abstract][Full Text] [Related]
19. Nanoparticlized System: Promising Approach for the Management of Alzheimer's Disease through Intranasal Delivery.
Bahadur S; Sachan N; Harwansh RK; Deshmukh R
Curr Pharm Des; 2020; 26(12):1331-1344. PubMed ID: 32160843
[TBL] [Abstract][Full Text] [Related]
20. Insights into direct nose to brain delivery: current status and future perspective.
Mittal D; Ali A; Md S; Baboota S; Sahni JK; Ali J
Drug Deliv; 2014 Mar; 21(2):75-86. PubMed ID: 24102636
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
